Brown, Lisle/Cummings’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43K | Hold |
132
| – | – | 0.01% | 350 |
|
|
2025
Q1 | $35.6K | Buy |
132
+7
| +6% | +$1.89K | 0.01% | 361 |
|
|
2024
Q4 | $29.4K | Hold |
125
| – | – | 0.01% | 375 |
|
|
2024
Q3 | $34.4K | Hold |
125
| – | – | 0.01% | 346 |
|
|
2024
Q2 | $30.4K | Hold |
125
| – | – | 0.01% | 350 |
|
|
2024
Q1 | $18.7K | Hold |
125
| – | – | 0.01% | 378 |
|
|
2023
Q4 | $23.9K | Hold |
125
| – | – | 0.01% | 346 |
|
|
2023
Q3 | $22.1K | Hold |
125
| – | – | 0.01% | 329 |
|
|
2023
Q2 | $23.7K | Hold |
125
| – | – | 0.01% | 325 |
|
|
2023
Q1 | $25K | Hold |
125
| – | – | 0.01% | 317 |
|
|
2022
Q4 | $29.7K | Buy |
+125
| New | +$29.7K | 0.02% | 298 |
|